Blanka Halamoda-Kenzaoui (PhD) from the EC Joint Research Centre works in the area of the regulatory science for nanomedicine.  Having a background in the pharmaceutical sciences she obtained a PhD in Life Sciences at University of Lausanne, Switzerland, for the work in the area of nanotoxicology. She has an expertise in nanotechnology, in vitro toxicology and method development.

Title of the talk (session 2.2 Nanomedicine and medical technologies):

The Regulatory Science Framework in nanomedicine: how science could improve the implementation of regulation?

Speaking points:

• Regulatory challenges for nano-enabled health products
• Harmonisation needs
• The REFINE H2020 project addressing regulatory science